News Wire

The World Health Organization (WHO) expects suspected links between the Zika virus and two neurological disorders, microcephaly in babies and Guillain-Barre syndrome, to be confirmed within weeks, according to a report from Reuters. “We have a few more weeks to be sure to demonstrate causality, but…
The U.S. will not screen people entering the country for the Zika virus because so many of those infected do not have symptoms, the Department of Homeland Security (DHS) has announced in a published statement. “Based on our current understanding of the virus, enhanced public health entry screening…
The original version of the Centers for Medicare and Medicaid Services’ (CMS) overpayments rule required physicians to sift through 10 years of claims to make sure Medicare had not overpaid them, but now a final rule, released on February 11, requires that docs look back only six years. “Specifying…
Many cancer patients find themselves in financial distress partly because the costs of cancer-fighting drugs are skyrocketing, according to an editorial in JAMA Oncology. Is it possible to create public policy that will rein in these prices and cut patients’ out-of-pocket costs? Not without significant…
Researchers at the Yale Cancer Center have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings, published in the New England Journal of Medicine, could fundamentally change the way this cancer and others are treated, the researchers say. Multiple myeloma…
During a recent public meeting held by the FDA’s Arthritis Advisory Committee to review the license application for CT-P13 (Celltrion), a proposed biosimilar to Remicade (infliximab, Janssen Biotech), the American College of Rheumatology (ACR) provided recommendations for policy guidelines to implement…
With a mortality rate of 0.1% and relatively few complications, 30-day readmissions represent one area in which bariatric surgery programs could improve, according to an article in the January/February 2016 issue of HealthLeaders magazine. About two-thirds of bariatric readmissions are preventable,…
Positive results from a pivotal phase III study investigating the use of eribulin mesylate injection (Halaven, Eisai, Inc.) in certain types of soft-tissue sarcoma have been published online in the Lancet. The study evaluated overall survival (OS, the primary endpoint) in previously treated patients…
Incyte Corporation has announced its decision to discontinue a phase II study (JANUS 1) of ruxolitinib or placebo in combination with capecitabine for the second-line treatment of patients with advanced or metastatic pancreatic cancer. The decision to stop the study was made after a planned interim…
Researchers in the United Kingdom are working on a urine test for prostate cancer that could make invasive diagnostic procedures a thing of the past. A pilot study included 155 men presenting to urology clinics. Of this group, 58 were diagnosed with prostate cancer, 24 with bladder cancer, and 73 with…
A new report from business intelligence provider GBI Research states that the Alzheimer’s disease market will more than double from just under $5 billion in 2014 to an estimated $10.4 billion in 2021, at a compound annual growth rate of 11%. This impressive market growth will occur across the eight…
Positive results have been reported from the second of two replicate pivotal phase III trials evaluating the efficacy and safety of elagolix (AbbVie/Neurocrine Biosciences) in premenopausal women with pain from endometriosis. After six months of continuous treatment, both doses of elagolix (150 mg once…
Previously, CTI BioPharma Corp. described a partial clinical hold issued on February 4 by the FDA regarding clinical studies being conducted under an investigational new drug (IND) application for the myelofibrosis treatment pacritinib. Now CTI BioPharma reports that studies of pacritinib have been…
Experts from the Centers for Disease Control and Prevention (CDC) are heading to Puerto Rico to determine whether the mosquito-borne Zika virus is linked to an increase in cases of Guillain-Barre syndrome, a rare neurological disorder, as the outbreak intensifies in that U.S. territory. “Right now…
The FDA’s Arthritis Advisory Committee has recommended approval of all eligible indications for CT-P13 (Celltrion/Pfizer), a proposed biosimilar to Janssen Biotech’s Remicade (infliximab), by a vote of 21 to 3. CT-P13 is the first biosimilar monoclonal antibody medication to be considered by the…

Pages